These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 21870732)

  • 21. Multichannel intraluminal impedance and pH monitoring in gastroesophageal reflux disease.
    Vela MF
    Expert Rev Gastroenterol Hepatol; 2008 Oct; 2(5):665-72. PubMed ID: 19072344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative study of salivary pH and volume in adults with chronic laryngopharyngitis by gastroesophageal reflux disease before and after treatment.
    Eckley CA; Costa HO
    Braz J Otorhinolaryngol; 2006; 72(1):55-60. PubMed ID: 16917554
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic laryngitis associated with gastroesophageal reflux: prospective assessment of differences in practice patterns between gastroenterologists and ENT physicians.
    Ahmed TF; Khandwala F; Abelson TI; Hicks DM; Richter JE; Milstein C; Vaezi MF
    Am J Gastroenterol; 2006 Mar; 101(3):470-8. PubMed ID: 16542282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Facts and Fantasies on Extraesophageal Reflux: A Gastroenterologist Perspective.
    Zerbib F; Dulery C
    J Clin Gastroenterol; 2017 Oct; 51(9):769-776. PubMed ID: 28858946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic strategies for laryngeal manifestations of gastroesophageal reflux disease.
    Yuksel ES; Vaezi MF
    J Clin Gastroenterol; 2013 Mar; 47(3):195-204. PubMed ID: 23340061
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of response to short-term proton pump inhibitor treatment in laryngopharyngeal reflux patients.
    Siupsinskiene N; Adamonis K; Toohill RJ; Sereika R
    J Laryngol Otol; 2008 Nov; 122(11):1206-12. PubMed ID: 18331659
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prolonged ambulatory pH monitoring in patients with persistent gastroesophageal reflux disease symptoms: testing while on therapy identifies the need for more aggressive anti-reflux therapy.
    Katzka DA; Paoletti V; Leite L; Castell DO
    Am J Gastroenterol; 1996 Oct; 91(10):2110-3. PubMed ID: 8855731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Gastroesophagopharyngeal reflux in infants and children with recurrent symptoms of the upper respiratory tract].
    Semeniuk J; Kaczmarski M; Sidor K; Krasnow A; Daniluk U; Matuszewska E
    Pol Merkur Lekarski; 2004 May; 16(95):461-4. PubMed ID: 15518427
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor?
    Hemmink GJ; Bredenoord AJ; Weusten BL; Monkelbaan JF; Timmer R; Smout AJ
    Am J Gastroenterol; 2008 Oct; 103(10):2446-53. PubMed ID: 18684197
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extraesophageal presentations of GERD: where is the science?
    Madanick RD
    Gastroenterol Clin North Am; 2014 Mar; 43(1):105-20. PubMed ID: 24503362
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New developments in gastroesophageal reflux disease diagnosis and therapy.
    Ali T; Miner PB
    Curr Opin Gastroenterol; 2008 Jul; 24(4):502-8. PubMed ID: 18622167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reflux monitoring: pH-metry, Bilitec and oesophageal impedance measurements.
    Pohl D; Tutuian R
    Best Pract Res Clin Gastroenterol; 2009; 23(3):299-311. PubMed ID: 19505660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Empiric trial of high-dose omeprazole in patients with posterior laryngitis: a prospective study.
    Wo JM; Grist WJ; Gussack G; Delgaudio JM; Waring JP
    Am J Gastroenterol; 1997 Dec; 92(12):2160-5. PubMed ID: 9399745
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Gastroesophageal reflux disease--diagnosis and management].
    Wojtuń S; Gil J; Jałocha Ł; Błaszak A; Wojtkowiak M
    Pol Merkur Lekarski; 2009 May; 26(155):512-6. PubMed ID: 19606713
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Therapy resistance of gastro-oesophageal reflux symptoms: acid reflux, non-acid reflux or no reflux].
    Bredenoord AJ; Smout AJ
    Ned Tijdschr Geneeskd; 2008 Nov; 152(47):2548-52. PubMed ID: 19174935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Benefit of acid-suppressive therapy in chronic laryngitis: the devil is in the details.
    Vaezi MF
    Clin Gastroenterol Hepatol; 2010 Sep; 8(9):741-2. PubMed ID: 20621625
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical trial: persistent gastro-oesophageal reflux symptoms despite standard therapy with proton pump inhibitors - a follow-up study of intraluminal-impedance guided therapy.
    Becker V; Bajbouj M; Waller K; Schmid RM; Meining A
    Aliment Pharmacol Ther; 2007 Nov; 26(10):1355-60. PubMed ID: 17900268
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnosis and management of laryngopharyngeal reflux disease.
    Remacle M; Lawson G
    Curr Opin Otolaryngol Head Neck Surg; 2006 Jun; 14(3):143-9. PubMed ID: 16728890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The value of a liquid alginate suspension (Gaviscon Advance) in the management of laryngopharyngeal reflux.
    McGlashan JA; Johnstone LM; Sykes J; Strugala V; Dettmar PW
    Eur Arch Otorhinolaryngol; 2009 Feb; 266(2):243-51. PubMed ID: 18506466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Laryngopharyngeal reflux].
    Takeda H; Oridate N; Shimizu Y; Kato M; Asaka M; Fukuda S; Yamamoto J
    Nihon Rinsho; 2007 May; 65(5):921-5. PubMed ID: 17511234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.